Translational Research Institute
Ryan Parlett is an accomplished professional in the life sciences and business development sectors, with a strong focus on commercial operations, industry engagement, and strategic management. Recent positions include Head of Commercial Operations and Business Development Lead at Translational Research Institute Australia, where Ryan contributed to the development of tenancy strategies and sales frameworks for an on-demand cGMP manufacturing facility. As Acting CEO of Life Sciences Queensland Ltd, Ryan conducted a strategic review and managed business operations. Previously, Ryan served as Senior Director of Business Development at BioCina and Director at Deloitte, specializing in cell and gene therapies. At Thermo Fisher Scientific, Ryan led new business development and government relations for the Pharma Services unit. Educational credentials include an Investment Foundations Certificate from the CFA Institute and a Foundations of Directorship from the Australian Institute of Company Directors.
This person is not in any teams
This person is not in any offices
Translational Research Institute
The Translational Research Institute (TRI) is a unique, Australian-first initiative of ‘bench to bedside’ medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.